Sector News

Biotech company funds research project on diversity

February 21, 2021
Life sciences

In collaboration with Genmab, a new anthropological postdoc project at the Department of Anthropology will now explore and help develop the company’s efforts to ensure a diverse and inclusive workplace.

The international biotech company Genmab has made it possible for the department to employ PhD in Anthropology Thomas Scott Hughes for a two-year postdoc project.

The project will focus on strengthening diversity and inclusion at Genmab. Genmab is experiencing strong growth and is interested in new knowledge on how the company can best attract and support a diverse workforce with an inclusive work culture in order to boost innovation.

“We operate in a global market where there is intensified competition in terms of attracting and retaining talent. We believe that workplace diversity and an inclusive work environment are prerequisite for the continued success of the company,” says Vibeke Didriksen, Senior Director, Head of Global Talent Management at Genmab.

Agreement after dialogue with AnthroAnalysis
Associate Professor Kasper Tang Vangkilde, who heads the department’s specialised unit for applied collaborations, AnthroAnalysis, has established the contact between Genmab and the Department of Anthropology.

At the beginning of last year, the two parties initiated a series of talks, which identified common interests in the research area known as D&I.

“We are pleased to be able to start a longer research collaboration with a private company of Genmab’s calibre and attract such a strong candidate for the project as Thomas Scott Hughes, who, with one leg in the research world and another in consulting, has the right profile to carry out the task,” says associate professor Kasper Tang Vangkilde.

“This project is also another clear sign that anthropology has become respected in business. We hope that the project will be one of many to come where anthropological research goes hand in hand with the development of organisations and business.”

Back to research
American-born Thomas Scott Hughes received his master’s degree from the Department of Anthropology in 2013. After years working as a research fellow at various research institutions, in 2014 he began work on an anthropology PhD project focusing on ethnic minorities with disabilities with full funding from a grant from the Ministry of Social Affairs.

For the past three years, he has been employed by the international consulting firm ReD Associates, where he worked with strategy development for large companies and NGOs. He was also chair of the Anthropologists’ Association in Denmark from 2015-2019.

“What is really exciting about this project is the opportunity to combine in-depth academic research with the development of practice-oriented solutions for a private company,” says Thomas Scott Hughes.

“By engaging with Genmab’s organisation over the next two years and conducting qualitative interviews, surveys and observations of the company’s working life, including their D&I initiatives, I will be able to develop both a strategic perspective on how best to promote diversity and inclusion in a company like Genmab, and contribute new knowledge to organisational and business anthropology.”

Strengthening knowledge about diversity
The project adds to the activities that are unfolding in the research group for organisation and economy called OREO at the Department of Anthropology. This subject area is a strategic focus for the department, with the ambition for anthropology to be more prevalent in relation to external companies and organisations.

“This new project also sharpens our profile in relation to work with diversity. Anthropologists have always dealt with diversity and dimensions of inequality in society, but it is new for us to focus on it specifically in business,” says Professor and Head of Department Bjarke Oxlund.

by University of Copenhagen, Press Release


comments closed

Related News

October 23, 2021

Novo Nordisk teams with CVS Health on obesity support program ahead of Wegovy DTC launch

Life sciences

As Novo Nordisk gears up to disrupt the obesity market with its newly approved weight-loss drug Wegovy, it is teaming with retail pharmacy giant CVS Health on a new education and nutrition coaching program for people taking anti-obesity meds.

October 23, 2021

GSK-backed Atreca inks license with Gates Medical Research Institute for malaria monoclonal antibody

Life sciences

The terms of the deal were undisclosed, but Atreca received $6 million from the Gates Foundation in 2012 to discover potential treatments for malaria, tuberculosis and HIV. The foundation has also given grant money to other biopharmas exploring malaria treatments, including Exscientia, which secured $4.2 million last year for such work.

October 23, 2021

A record number of biotechs are going public. Here’s how they’re performing.

Life sciences

At the start of the last decade, the IPO markets weren’t receptive to biotech companies. But by 2013, public investment was pouring into the industry, drawn by scientific advances and boosted by the newfound interest of a broader range of investors. Ever since, biotechs and their backers have ridden a multi-year boom. Keep track of them as they happen with this database.

Send this to a friend